Is the new medicine for arthritis, leukaemia and multiple sclerosis called TGN1412, which was life-threatening for volunteers on whom the product was tested in the UK, available in the Czech Republic?

The substance which caused the adverse reactions in the UK has not been approved for use in any clinical trial in the Czech Republic.